Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Oprah Winfrey is spilling the truth about “thin people” after her diet drug journey. Knewz.com can reveal the media mogul, ...

A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

One thing that doesn't seem to leave the conversation in 2025, after its meteoric yet controversial rise in 2023 and 2024, is the Ozempic phenomenon. A prescription drug, Ozempic has been making its ...

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as possible dangers.

Panorama is shining a light on the use of weight loss medications ... to a study funded by a drug manufacturer. The five-year study looked at semaglutide – a prescription drug offered by ...